Analysis of factors influencing clinical pregnancy rates in frozen-thawed embryo transfer cycles
- PMID: 40636712
- PMCID: PMC12237683
- DOI: 10.3389/fendo.2025.1551530
Analysis of factors influencing clinical pregnancy rates in frozen-thawed embryo transfer cycles
Abstract
Objective: To identify the determinants influencing clinical pregnancy outcomes in frozen-thawed embryo transfer (FET) cycles.
Methods: A retrospective analysis was conducted on patients who underwent FET at the Department of Reproductive Genetics, The First Affiliated Hospital of Kunming Medical University, between January 2018 and December 2023. A total of 7,302 FET cycles were included and categorized into two groups based on clinical pregnancy outcomes: the clinical pregnancy group (n = 3,365) and the non-clinical pregnancy group (n = 3,937). Baseline characteristics were compared between groups. A random forest algorithm was applied to rank the importance of variables, followed by dimensionality reduction using a sliding window sequential forward selection (SWSFS) method. The top-ranked predictors with the lowest average out-of-bag (OOB) error rates were incorporated into a multivariate logistic regression model to determine independent predictors of clinical pregnancy in FET cycles.
Results: The overall clinical pregnancy rate (CPR) was 46.08%. The CPR was significantly higher in blastocyst transfers (61.14%) compared to cleavage-stage embryo transfers (34.13%) (χ² = 528.973, P < 0.01). The random forest model identified seven variables with the highest predictive value: female age, number of high-quality blastocysts, anti-Müllerian hormone (AMH) level, embryo stage at transfer, endometrial thickness on the day of transfer, number of high-quality cleavage-stage embryos, and pre-transfer endometrial thickness. Multivariate logistic regression analysis demonstrated that younger female age (OR: 0.93; 95% CI: 0.92-0.94), greater number of high-quality blastocysts (OR: 1.67; 95% CI: 1.49-1.88), higher AMH levels (OR: 1.03; 95% CI: 1.01-1.05), blastocyst transfer (OR: 2.31; 95% CI: 1.85-2.88), increased endometrial thickness on transfer day (OR: 1.10; 95% CI: 1.05-1.15), more high-quality cleavage-stage embryos (OR: 1.74; 95% CI: 1.59-1.92), and greater pre-transfer endometrial thickness (OR: 1.04; 95% CI: 1.00-1.09) were all independently associated with higher clinical pregnancy rates.
Conclusion: Female age, number of high-quality blastocysts, AMH levels, embryo stage at transfer, endometrial thickness on the day of transfer, number of high-quality cleavage-stage embryos, and pre-transfer endometrial thickness are significant predictors of clinical pregnancy outcomes in FET cycles. These findings may guide individualized embryo transfer strategies to optimize reproductive success.
Keywords: assisted reproductive technology; clinical pregnancy; female age; frozen-thawed embryo transfer; influencing factors.
Copyright © 2025 Wang, Yang, Chen, Gao, Zhao, Cao, Li and He.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology.Cochrane Database Syst Rev. 2022 May 19;5(5):CD002118. doi: 10.1002/14651858.CD002118.pub6. Cochrane Database Syst Rev. 2022. PMID: 35588094 Free PMC article.
-
A randomized controlled trial comparing embryo vitrification with slush nitrogen to liquid nitrogen in women undergoing frozen embryo transfer: embryology and clinical outcomes.Hum Reprod. 2025 Mar 1;40(3):426-433. doi: 10.1093/humrep/deaf003. Hum Reprod. 2025. PMID: 39836897 Clinical Trial.
-
Cycle regimens for frozen-thawed embryo transfer.Cochrane Database Syst Rev. 2017 Jul 5;7(7):CD003414. doi: 10.1002/14651858.CD003414.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2025 Jun 3;6:CD003414. doi: 10.1002/14651858.CD003414.pub4. PMID: 28675921 Free PMC article. Updated.
-
Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology.Cochrane Database Syst Rev. 2016 Jun 30;(6):CD002118. doi: 10.1002/14651858.CD002118.pub5. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2022 May 19;5:CD002118. doi: 10.1002/14651858.CD002118.pub6. PMID: 27357126 Updated.
-
Intra-individual variability of serum progesterone levels on the day of frozen blastocyst transfer in hormonal replacement therapy cycles.Hum Reprod. 2024 Apr 3;39(4):742-748. doi: 10.1093/humrep/deae015. Hum Reprod. 2024. PMID: 38332539
References
-
- Fauser BCJM, Adamson GD, Boivin J, Chambers GM, de Geyter C, Dyer S, et al. Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature. Hum Reprod Update. (2024) 30:153–73. doi: 10.1093/humupd/dmad028 - DOI - PMC - PubMed
-
- Liu MF, Zhang F, Zhao H. Frontiers of reproductive health research (in Chinese). Sci Sin Vitae. (2024) 54:1–3. doi: 10.1360/SSV-2024-0010 - DOI
-
- Chang C-T, Weng S-F, Chuang H-Y, Hsu I-L, Hsu C-Y, Tsai E-M. Embryo transfer impact: a comprehensive national cohort analysis comparing maternal and neonatal outcomes across varied embryo stages in fresh and frozen transfers. Front Endocrinol. (2024) 15:1400255. doi: 10.3389/fendo.2024.1400255 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources